Please assess the completion status of the following clinical trial:

Trial Title: Open Label Study of Duloxetine for the Treatment of Phantom Limb Pain

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Chronic PLP \> 6 months~2. Short-Form McGill Pain Questionnaire Sensory Pain Rating Index raw score ≥ 16~3. Age ≥ 18 years old~4. Inpatient or Outpatient~5. Able to come to all appointments, in the opinion of the investigator~6. Able to give informed consent, in opinion of investigator~Exclusion Criteria:~1. Current Major Depressive disorder, Anxiety Disorder, or Psychotic disorder assessed by the Mini International Neuropsychiatric Interview (MINI)~2. Substance abuse or dependence within the last six months, as assessed by the MINI~3. Known Diabetes Mellitus to exclude diabetic peripheral neuropathy~4. History of coronary artery disease, hepatic disease, renal disease~5. Other pain syndromes~6. Any unstable medical conditions in the opinion of the investigator~7. Other psychotropic medications excluding hypnotics

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).